Your browser doesn't support javascript.
loading
Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats.
Zhou, Lin; Yan, Fengjuan; Jiang, Rui; Liu, Jing; Cai, Limin; Wang, Yongchen.
Afiliación
  • Zhou L; Department of General Practice, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
  • Yan F; Department of General Practice, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
  • Jiang R; Department of General Practice, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
  • Liu J; Department of Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Cai L; Department of Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Wang Y; Department of General Practice, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Oxid Med Cell Longev ; 2021: 9930187, 2021.
Article en En | MEDLINE | ID: mdl-34745427
Ulcerative colitis (UC) is a common chronic nonspecific intestinal inflammation of unknown etiology associated with a low cure rate and a high relapse rate. Hair follicle mesenchymal stem cells (HF-MSCs) are a class of pluripotent stem cells that have differentiation potential and strong proliferation ability. Nuclear factor red system related factor (Nrf-2) is a key factor in the oxidative stress response. Dextran sulfate sodium- (DSS-) induced rat UC models closely mimic human UC in terms of symptoms and histological changes. Animals were divided into five groups, including a healthy group and UC model rats treated with normal saline, Nrf-2, HF-MSCs, or Nrf-2-expressing HF-MSC group. Based on the expression of intestinal stem cells, inflammatory factors, anti-inflammatory factors, and disease activity index scores, Nrf-2-expressing HF-MSCs had the most obvious therapeutic effect under the same treatment regimen. This study provided a new potential clinical treatment option for ulcerative colitis.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Sulfato de Dextran / Folículo Piloso / Trasplante de Células Madre Mesenquimatosas / Factor 2 Relacionado con NF-E2 / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Sulfato de Dextran / Folículo Piloso / Trasplante de Células Madre Mesenquimatosas / Factor 2 Relacionado con NF-E2 / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China